Organigram Holdings Inc. income statement OGI

Annual Quarterly

USD in millions, except per-share amounts and margins. The percent under a figure is the change from the year before.

Line
FY 2022
Aug 31, 2022
FY 2021
Aug 31, 2021
Income tax
-0
0
Weighted average shares, basic
77
-69.8%
256
+48.3%
Weighted average shares, diluted
77
-69.8%
256
+43.8%
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. More on our methodology.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
OGI (Nasdaq)
Fiscal year ends
September 30
Incorporated in
Canada (Federal Level)
Headquarters
Toronto
SEC filer status
, Emerging growth company
SEC CIK
1620737
Former names
ORGANIGRAM HOLDINGS INC. (until Apr 1, 2025); ORGANIGRAM HOLDINGS INC (until Jul 21, 2016)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.